Skip to content
healthcare.dev

Mucinex Sinus-Max Severe Congestion Relief

NDC 63824-201, Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride, tablet, coated, from Reckitt Benckiser LLC.

Product NDC
63824-201
Status
Listed
Labeler
Reckitt Benckiser LLC
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63824-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETAMINOPHEN325 mg/1
  • GUAIFENESIN200 mg/1
  • PHENYLEPHRINE HYDROCHLORIDE5 mg/1

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
63824-201-44638240201444 POUCH in 1 CARTON (63824-201-44) / 2 TABLET, COATED in 1 POUCH (63824-201-72)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63824-201 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63824-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63824-201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.